behavioural health

[Left] Adam Hutchinson, founder of oVRcome, and [Right] Dr Cameron Lacey of the University of Otago
By  Adam Ang 01:14 am July 21, 2022
A clinical trial in New Zealand found a virtual reality app-based cognitive behaviour therapy programme reduced the symptoms of common phobias. FINDINGS Conducted between May and December last year, the randomised, controlled trial recruited a total of 129 adult participants with fears of flying, heights, needles, spiders and dogs. It was led by Dr Cameron Lacey, associate professor from the...
Alt text: A child playing on an iPad
By  Adam Ang 04:08 am August 26, 2021
The University of Southern Queensland in Australia has disclosed that a global research team is developing a unique classification system for the early detection of autism in children. WHAT IT'S ABOUT In a study, whose findings were published in the journal Complex & Intelligent Systems, the researchers examined and tested two sets of nonlinear, highly distinctive features of EEG signals...
Holmusk's mConnect platform integrates patient-reported outcomes and EHR clinical data.
By  Adam Ang 02:47 am August 18, 2021
Holmusk, a health tech firm based in Singapore and New York, has signed deals to use patient data from the University of Texas Health Science Center and the Harris Center for Mental Health and IDD to develop AI-powered analytic tools. WHY IT MATTERS The company will help create longitudinal patient records in both centres, which are still storing data in various legacy electronic health record...
By  Adam Ang 02:43 am July 14, 2021
Sydney-headquartered telehealth platform Eucalyptus has recently bagged A$30 million ($22.4 million) in a Series B funding round led by NewView Capital, the Silicon Valley-based investor that also backs digital health firms 23andMe and Hims & Hers. The investing round also saw participation from previous investors Blackbird Ventures and W23, as well as new investor AirTree Ventures. WHAT IT...
By  Adam Ang 02:52 am July 8, 2021
New Jersey-based Otsuka Pharmaceutical Development & Commercialization has signed a three-year collaboration with Holmusk, a data science and digital health firm based in Singapore and New York. The deal is worth up to $4 million annually. WHAT THEY DO OPDC is an indirect unit of Otsuka Pharmaceutical Company, which is a subsidiary of Japan-based Otsuka Holdings. It develops and manufactures...